Your browser doesn't support javascript.
loading
Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease.
Menke, Marcel N; Framme, Carsten; Nelle, Mathias; Berger, Markus R; Sturm, Veit; Wolf, Sebastian.
Afiliação
  • Menke MN; Department of Ophthalmology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland. marcel.menke@ksa.ch.
  • Framme C; Department of Ophthalmology, Cantonal Hospital Aarau, Aarau, Switzerland. marcel.menke@ksa.ch.
  • Nelle M; Department of Ophthalmology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland. framme.carsten@mh-hannover.de.
  • Berger MR; University Eye Hospital, Medical School Hannover, Hannover, Germany. framme.carsten@mh-hannover.de.
  • Sturm V; Department of Neonatology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland. mathias.nelle@insel.ch.
  • Wolf S; Department of Neonatology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland. markus.berger@insel.ch.
BMC Ophthalmol ; 15: 20, 2015 Mar 08.
Article em En | MEDLINE | ID: mdl-25886603
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Retinopatia da Prematuridade / Neovascularização Retiniana / Inibidores da Angiogênese / Ranibizumab Limite: Female / Humans / Newborn Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Retinopatia da Prematuridade / Neovascularização Retiniana / Inibidores da Angiogênese / Ranibizumab Limite: Female / Humans / Newborn Idioma: En Ano de publicação: 2015 Tipo de documento: Article